Patents by Inventor John C. Babcock
John C. Babcock has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20240101791Abstract: Described herein are improved thermoplastic composites, which demonstrate excellent physical properties, such as yield strength, ultimate tensile strength, toughness, elongation, and, optionally, superior tunable biodegradability when compared to known thermoplastics. The composite comprises minimally a thermoplastic polymer, at least one phenolic compound, and, optionally, a filler.Type: ApplicationFiled: September 28, 2023Publication date: March 28, 2024Applicant: WARNER BABCOCK INSTITUTE FOR GREEN CHEMISTRY, LLCInventors: Christopher William Livesey, Alexander Hsu, Brandon Ackley, Samuel Ellman, Frederick Richard Kearney, John C. Warner, Joseph Luke Pont, James V. Babcock
-
Patent number: 5918394Abstract: A paperboard picture frame is described which is particularly suitable for binding with calendar pages to provide personalized photocalendars. The picture frame includes a backing panel including slits formed therein, a frame panel with a window defined therein, and a base panel, all of which are preferably made of paperboard, e.g., cardstock. The frame panel is attached to the backing panel at a first folding edge, and the base panel is attached to the frame panel at a second folding edge. The slits in the backing panel may accommodate the edges of a photograph so that the photograph is held against the backing panel. A generally transparent cover sheet is then provided which may have its edges inserted within the slits of the backing panel so that the cover sheet rests above the photograph for protective purposes.Type: GrantFiled: June 16, 1997Date of Patent: July 6, 1999Assignee: Remember When, Inc.Inventor: John C. Babcock
-
Patent number: 5538721Abstract: The invention provides methods for stabilizing amino-substituted steroid therapeutic agents in topical ophthalmic and other pharmaceutical formulations using effective stabilizing amounts of lightly cross-linked carboxy-containing polymers; and methods for stabilizing and solubilizing amino-substituted steroid therapeutic agents in such pharmaceutical formulations using effective stabilizing amounts of lightly cross-linked carboxy-containing polymers and amounts of selected cyclodextrin derivatives sufficient to at least partially solubilize the therapeutic agents. The cyclodextrin derivatives are selected from the group consisting of the hydroxypropyl, hydroxyethyl, glucosyl, maltosyl and maltotriosyl derivatives of .beta.- and .gamma.-cyclodextrin. Stabilized and stabilized/solubilized pharmaceutical compositions adapted for various routes of administration are also described.Type: GrantFiled: February 28, 1994Date of Patent: July 23, 1996Assignee: InSite Vision IncorporatedInventors: John C. Babcock, Jon R. Polansky, Lyle M. Bowman, Sheng-Wan Tsao, Erwin C. C. Si, Santosh K. Chandrasekaran
-
Patent number: 5332582Abstract: The invention provides methods for stabilizing amino-substituted steroid therapeutic agents in topical ophthalmic and other pharmaceutical formulations using effective stabilizing amounts of lightly cross-linked carboxy-containing polymers; Stabilized and stabilized/solubilized pharmaceutical compositions adapted for various routes of administration are also described.Type: GrantFiled: December 2, 1992Date of Patent: July 26, 1994Assignee: Insite Vision IncorporatedInventors: John C. Babcock, Jon R. Polansky, Lyle M. Bowman, Sheng-Wan Tsao, Erwin C. Si, Santosh K. Chandrasekaran
-
Patent number: 5252319Abstract: Methods and compositions for preventing or treating ophthalmic diseases or disorders wherein an ophthalmically effective amount of the C.sub.20 through C.sub.26 aminosteroids of formula XI and their pharmaceutical, acceptable salts, hydrates or solvates is administered in an inert vehicle to arrest oxidation processes damaging to the eye.Type: GrantFiled: February 19, 1992Date of Patent: October 12, 1993Assignee: Insite Vision IncorporatedInventors: John C. Babcock, Jon R. Polansky, Lyle M. Bowman, Sheng-Wan Tsao, Erwin C.-C. Si, Santosh K. Chandrasekaran
-
Patent number: 5209926Abstract: Methods and compositions for preventing or treating ophthalmic diseases or disorders wherein an ophthalmically effective amount of the C.sub.20 through C.sub.26 aminosteroids of formula XI and their pharmaceutical, acceptable salts, hydrates or solvates is administered in an inert vehicle to arrest oxidation processes damaging to the eye.Type: GrantFiled: August 24, 1992Date of Patent: May 11, 1993Assignee: InSite Vision IncorporatedInventors: John C. Babcock, Jon R. Polansky, Lyle M. Bowman, Sheng-Wan Tsao, Erwin C. Si, Santosh K. Chandrasekaran
-
Patent number: 5188826Abstract: A topical, aqueous ophthalmic gel suspension for dry eye is administrable to the eye in drop form, remains as a gel in the eye for a prolonged time, and releases water and one or more ophthalmic demulcents or vasoconstrictors. It comprises water and from 0.1% to 6.5% by weight of lightly cross-linked carboxyl-containing polymer having a particle size of not more than about 50 .mu.m in equivalent spherical diameter. The suspension is at a pH of from 6.6 to 8.0, has an osmolality of from 50 to 400 mOsM, and a viscosity of from about 500 to about 4,000 centipoise (0.5 to 4 Pa.s).Type: GrantFiled: July 6, 1990Date of Patent: February 23, 1993Assignee: InSite Vision IncorporatedInventors: Santosh K. Chandrasekaran, Margaret J. Reents, John C. Babcock, Lyle M. Bowman, Roy D. Archibald, Joseph R. Robinson
-
Patent number: 5124154Abstract: Methods and compositions for preventing or treating ophthalmic diseases or disorders wherein an ophthalmically effective amount of the C.sub.20 through C.sub.26 aminosteroids of formula XI and their pharmaceutical, acceptable salts, hydrates or solvates is administered in an inert vehicle to arrest oxidation processes damaging to the eye.Type: GrantFiled: June 12, 1990Date of Patent: June 23, 1992Assignee: InSite Vision IncorporatedInventors: John C. Babcock, Jon R. Polansky, Lyle M. Bowman, Sheng-Wan Tsao, Erwin C. Si, Santosh K. Chandrasekran
-
Patent number: 4297350Abstract: The steroids of the present invention have been found to be useful as male contraceptives when administered orally. Upon cessation of administration of the male contraceptive steroids of the present invention the male promptly regains normal fertility.Type: GrantFiled: October 10, 1978Date of Patent: October 27, 1981Assignee: The Upjohn CompanyInventors: John C. Babcock, J. Allan Campbell, Thomas J. Lobl
-
Patent number: 4013688Abstract: Novel steroid derivatives containing a tyrosine ester amide group linked to an 11-hydroxysteroid alkylene dicarboxylic hemi-ester are described, suitable for iodination with radioactive iodine, useful in radioimmunoassay.Type: GrantFiled: December 20, 1972Date of Patent: March 22, 1977Assignee: The Upjohn CompanyInventors: John C. Babcock, J. Allan Campbell
-
Patent number: 4004003Abstract: A process for the prevention or treatment of osteoporosis induced as a side effect of the administration of glucocorticoid steroids by the administration of a compound of the formula: ##STR1## WHEREIN R.sub.1 and R.sub. 2 are the same or different radicals selected from the group consisting of hydrogen, alkyl of less than 9 carbon atoms, and phenyl; R.sub.3 and R.sub. 5 are selected from the group consisting of hydrogen and lower acyl; n is an integer, selected from the group consisting of 2, 3, and 4; or a hydrate thereof in association with a pharmaceutical carrier to a human or animal being treated or having been treated with a gluco-corticoid hormone.Type: GrantFiled: October 6, 1975Date of Patent: January 18, 1977Assignee: The Upjohn CompanyInventors: John C. Babcock, J. Allan Campbell
-
Patent number: 3980638Abstract: Novel testosterone 17-ether 2,3-isoxazole and 2-cyano derivatives are disclosed as useful steroid enzyme inhibitors and for other pharmaceutical purposes.Type: GrantFiled: September 20, 1974Date of Patent: September 14, 1976Assignee: The Upjohn CompanyInventors: John C. Babcock, J. Allan Campbell
-
Patent number: 3937827Abstract: Compounds of the formula: ##SPC1##Wherein R is hydrogen prepared in unit dosage form with appropriate pharmaceutical carrier for oral and parenteral administration and process of producing regression in subjects with advanced or disseminated mammary cancer in woman.Type: GrantFiled: August 30, 1974Date of Patent: February 10, 1976Assignee: The Upjohn CompanyInventors: John C. Babcock, Roman P. Holysz